Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Maryam, Lustberg"'
Autor:
Payton De La Cruz, Julia McAdams, Melanie Morales Aquino, Aileen I. Fernandez, Andrew Elliott, Maryam Lustberg, Christoph Schorl, Jennifer R. Ribeiro, Nicole E. James
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-19 (2024)
Abstract Background Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer. While PD-1 based immunotherapies overall have led to improved treatment outcomes for this disease, a diverse response to frontline chemotherapy
Externí odkaz:
https://doaj.org/article/d70bfb940b8c4a6e827519886136689e
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Sex disparities are known modifiers of health and disease. In neuroendocrine neoplasms (NENs), sex-based differences have been observed in the epidemiology and treatment-related side effects. Objectives: To examine sex differences in demo
Externí odkaz:
https://doaj.org/article/98710cbfd07c41e2855622fe4246dd71
Autor:
Kai C. C. Johnson, Ai Ni, Dionisia Quiroga, Ashley C. Pariser, Preeti K. Sudheendra, Nicole O. Williams, Sagar D. Sardesai, Mathew Cherian, Daniel G. Stover, Margaret Gatti-Mays, Bhuvaneswari Ramaswamy, Maryam Lustberg, Sachin Jhawar, Roman Skoracki, Robert Wesolowski
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract There is limited data regarding the added benefit of adjuvant systemic therapy in the management of small, node-negative, HER2+ breast cancer. In a multi-institutional retrospective analysis using the American Society of Clinical Oncology Ca
Externí odkaz:
https://doaj.org/article/fc9fb37c438d44728b8717088153f8ae
Autor:
Jasmine S. Sukumar, Sagar Sardesai, Andy Ni, Nicole Williams, Kai Johnson, Dionisia Quiroga, Bhuvana Ramaswamy, Robert Wesolowski, Mathew Cherian, Daniel G. Stover, Margaret Gatti‐Mays, Ashley Pariser, Preeti Sudheendra, Mridula A. George, Maryam Lustberg
Publikováno v:
Cancer Medicine, Vol 13, Iss 12, Pp n/a-n/a (2024)
Abstract Background The optimal adjuvant endocrine therapy (ET) in hormone receptor positive (HR+) and human epidermal growth factor receptor 2 positive (HER2+) premenopausal breast cancer (BC) remains unclear. Moreover, the benefit and clinical indi
Externí odkaz:
https://doaj.org/article/95ee2addb7d44134809b3c59d72db720
Autor:
Dionisia Quiroga DO, PhD, Robert Wesolowski MD, Sara Zelinskas BS, Ashley Pinette MD, Brooke Benner PhD, Emily Schwarz BS, Himanshu Savardekar BS, Courtney Johnson DO, Andrew Stiff MD, PhD, Lianbo Yu PhD, Erin Macrae MD, Maryam Lustberg MD, MPH, Ewa Mrozek MD, Bhuvaneswari Ramaswamy MD, William E. Carson MD
Publikováno v:
Cancer Control, Vol 31 (2024)
Objectives CpG ODN is a Toll-like receptor 9 agonist with immunotherapeutic potential for many cancer types, including aggressive breast cancers. There is strong interest in utilizing CpG ODN as an adjuvant to improve clinical efficacy of current tre
Externí odkaz:
https://doaj.org/article/c4a04ac8a9714a0fa31cf6f588fbd325
Autor:
Leah S. Puklin, Fangyong Li, Brenda Cartmel, Julian Zhao, Tara Sanft, Alexa Lisevick, Eric P. Winer, Maryam Lustberg, Donna Spiegelman, Mona Sharifi, Melinda L. Irwin, Leah M. Ferrucci
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-9 (2023)
Abstract Weight gain after breast cancer diagnosis is associated with adverse health outcomes. Yet, few studies have characterized post-diagnosis weight change in the modern treatment era or populations most at risk for weight changes. Among women di
Externí odkaz:
https://doaj.org/article/2e23643bebf84ac29dc48ce6c3ef0219
Autor:
Darren Haywood, Moira O’Connor, Frank D. Baughman, Alexandre Chan, Raymond J. Chan, Evan Dauer, Haryana M. Dhillon, Ashley M. Henneghan, Blake J. Lawrence, Maryam Lustberg, Janette L. Vardy, Susan L. Rossell, Nicolas H. Hart
Publikováno v:
Methods and Protocols, Vol 7, Iss 4, p 54 (2024)
(1) Background: A significant proportion of cancer survivors report experiencing a cognitive ‘fog’ that affects their ability to think coherently and quickly, and reason with clarity. This has been referred to as cancer-related cognitive impairme
Externí odkaz:
https://doaj.org/article/308e2d44f6b94c168acdffc33bee4791
Autor:
Nicole O. Williams, Dionisia Quiroga, Courtney Johnson, Adam Brufsky, Mara Chambers, Saveri Bhattacharya, Maria Patterson, Sagar D. Sardesai, Daniel Stover, Maryam Lustberg, Anne M. Noonan, Mathew Cherian, Darlene M. Bystry, Kasey L. Hill, Min Chen, Mitch A. Phelps, Michael Grever, Julie A. Stephens, Bhuvaneswari Ramaswamy, William E. Carson, Robert Wesolowski
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: Heat shock protein 90 (HSP90) is a molecular chaperone required for stabilization of client proteins over-activated in triple-negative breast cancer (TNBC). Over-expression of HSP90 client proteins has been implicated in paclitaxel resist
Externí odkaz:
https://doaj.org/article/c53632218637477c91145bbc4eb4d598
Autor:
Rebecca R. Carter, Aaron P. Chum, Reynaldo Sanchez, Avirup Guha, Amit K. Dey, Raquel Reinbolt, Lisa Kim, Prince Otchere, Oduro Oppong‐Nkrumah, William T. Abraham, Maryam Lustberg, Daniel Addison
Publikováno v:
Cancer Medicine, Vol 12, Iss 1, Pp 297-305 (2023)
Abstract Background Contemporary therapies improve breast cancer (BC) outcomes. Yet, many of these therapies have been increasingly linked with serious cardiotoxicity, including reports of profound hypertension. Yet, the incidence, predictors, and im
Externí odkaz:
https://doaj.org/article/b98526d799604c008fd0092db7ca46e3
Autor:
Corina J. G. van den Hurk, Floortje Mols, Manuela Eicher, Raymond J. Chan, Annemarie Becker, Gijs Geleijnse, Iris Walraven, Annemarie Coolbrandt, Maryam Lustberg, Galina Velikova, Andreas Charalambous, Bogda Koczwara, Doris Howell, Ethan M. Basch, Lonneke V. van de Poll-Franse
Publikováno v:
Current Oncology, Vol 29, Iss 6, Pp 4370-4385 (2022)
Electronic patient-reported outcome (ePRO) applications promise great added value for improving symptom management and health-related quality of life. The aim of this narrative review is to describe the collection and use of ePROs for cancer survivor
Externí odkaz:
https://doaj.org/article/b392c6483593407a99f14b4c584f4b98